| Net income | 844.81M |
| Depreciation and amortization | |
| Stock-based compensation expense | 29.82M |
| Tax benefits from stock award exercises | |
| Excess tax benefits from stock award exercises | -12.58M |
| Deferred income taxes | 48.78M |
| Equity investment income, net | 16.83M |
| Loss on disposal of assets and other non-cash charges | |
| Goodwill impairment charge | 253M |
| Debt redemption charges | |
| Accounts receivable | -85.66M |
| Inventories | -13.05M |
| Other receivables and other current assets | -1.62M |
| Other long-term assets | |
| Accounts payable | -45.51M |
| Accrued compensation and benefits | 79.29M |
| Other current liabilities | 119.55M |
| Income taxes | 65.16M |
| Other long-term liabilities | |
| Net cash provided by operating activities | |
| Additions of property and equipment, net | -575.24M |
| Acquisitions | |
| Proceeds from asset sales | |
| Purchase of investments available for sale | -9.04M |
| Purchase of investments held-to-maturity | -976.41M |
| Proceeds from sale of investments available for sale | 8.64M |
| Proceeds from maturities of investments held-to-maturity | |
| Purchase of equity investments and other assets | |
| Distributions received on equity investments | |
| Net cash used in investing activities | |
| Borrowings | 39.1B |
| Payments on long-term debt | |
| Interest rate cap premiums and other deferred financing costs | |
| Debt call premium | |
| Purchase of treasury stock | -620.9M |
| Distributions to noncontrolling interests | |
| Stock award exercises and other share issuances, net | 18.52M |
| Excess tax benefits from stock award exercises | 12.58M |
| Contributions from noncontrolling interests | |
| Proceeds from sales of additional noncontrolling interests | |
| Purchases from noncontrolling interests | -9.73M |
| Net cash used in financing activities | |
| Net (decrease) increase in cash and cash equivalents | -585.62M |
| Cash and cash equivalents at beginning of period | 1.5B |
| Cash and cash equivalents at end of period | 913.5M |